Replay available

Ginkgo Bioworks Holdings Inc (DNA) Q1 2025 Earnings Call

Ginkgo Bioworks Holdings Inc (NYSE: DNA) Q1 2025 earnings conference call, held 2025-05-06. Replay captured from the company's public earnings webcast.

Tue, May 6, 2025 at 5:30 PMendedReplay
Ginkgo Bioworks Holdings Inc (DNA) Q1 2025 Earnings Call

Hosted by

Featured presenters

Jason Kelly

Co-founder and CEO

Mark Dimitrick

CFO

Michael Riskin

Analyst, Bank of America

Josh Triplett

Analyst

Mark Massaro

Analyst, BTIG

Matt Sykes

Analyst, Goldman Sachs

Matt LaRue

Analyst, William Blair

Investor webinar replay

Watch the replay and follow the connected company analysis, news, and investor updates for Ginkgo Bioworks Holdings, Inc..

Watch the replay

Replay transcript excerpt

WEBVTT 00:00:00.031 -- 00:00:03.737 communications and ownership. It's my third year here at Ginkgo. 00:00:03.737 -- 00:00:07.623 I've spent much of that time working behind the scenes with our investor relations team 00:00:07.623 -- 00:00:11.489 on these earnings calls, but I'm thrilled to be joining you for the first time live on 00:00:11.489 -- 00:00:17.338 air. I'm joined by Jason Kelly, our co-founder and CEO, and Mark Dimitrick, our CFO. 00:00:17.338 -- 00:00:22.745 Thanks as always for joining us. We're looking forward to updating you on our progress. 00:00:22.745 -- 00:00:26.849 As a reminder, during the presentation today, we'll be making forward-looking statements 00:00:26.849 -- 00:00:31.974 which involve risks and uncertainties. Please refer to our filings with the SEC to learn 00:00:31.974 -- 00:00:37.019 more about these risks and uncertainties, including our most recent 10-K. 00:00:37.019 -- 00:00:41.003 Today, in addition to updating you on the quarter results, we're going to provide updates 00:00:41.003 -- 00:00:45.607 on our path towards adjusted EBITDA breakeven, traction with our government clients, 00:00:45.607 -- 00:00:49.947 as well as new offerings and opportunities emerging for our tools businesses. 00:00:49.947 -- 00:00:55.098 As usual, we'll end with a Q&A session, and I'll take questions from analysts, investors, 00:00:55.098 -- 00:01:01.210 and the public. You can submit those questions to us in advance via X, hashtag GinkgoResults, 00:01:01.210 -- 00:01:04.794 or email investors at ginkgobioworks.com. 00:01:05.058 -- 00:01:07.092 All right, over to you, Jason. 00:01:07.092 -- 00:01:10.658 Thanks, Daniel. We always start off with our mission here at Ginkgo, which is to make 00:01:10.658 -- 00:01:14.385 biology easier to engineer. And then...